High Purity XCE Tirzepatide LY3298176 99% White Powder for Laboratory Use

XCE Tirzepatide (LY3298176) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. This innovative compound demonstrates significantly enhanced efficacy in glucose regulation and weight management compared to single-receptor agonists.

The XCE Tirzepatide formulation exhibits preferential binding to GIP receptors while maintaining potent GLP-1 receptor activity. This unique pharmacological profile has shown superior hyperglycemia reduction in research settings compared to selective GLP-1 receptor agonists. The compound effectively mimics natural GIP activity at receptor sites.

Our XCE Tirzepatide is supplied as a high-purity white powder suitable for research applications. The product undergoes rigorous quality control testing to ensure consistent performance in laboratory studies. Researchers value its stability and reproducible results in metabolic research.

This product is intended for research use only, not for human consumption. Proper laboratory handling procedures should be followed when working with XCE Tirzepatide. Researchers should consult relevant literature for appropriate experimental protocols.